396 related articles for article (PubMed ID: 11298092)
1. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism.
Homsanit M; Sriussadaporn S; Vannasaeng S; Peerapatdit T; Nitiyanant W; Vichayanrat A
Clin Endocrinol (Oxf); 2001 Mar; 54(3):385-90. PubMed ID: 11298092
[TBL] [Abstract][Full Text] [Related]
2. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
3. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
[TBL] [Abstract][Full Text] [Related]
4. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
[TBL] [Abstract][Full Text] [Related]
5. Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism.
Okamura K; Ikenoue H; Shiroozu A; Sato K; Yoshinari M; Fujishima M
J Clin Endocrinol Metab; 1987 Oct; 65(4):719-23. PubMed ID: 3654917
[TBL] [Abstract][Full Text] [Related]
6. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease.
Kallner G; Vitols S; Ljunggren JG
J Intern Med; 1996 Jun; 239(6):525-9. PubMed ID: 8656146
[TBL] [Abstract][Full Text] [Related]
7. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil.
Momotani N; Yamashita R; Makino F; Noh JY; Ishikawa N; Ito K
Clin Endocrinol (Oxf); 2000 Aug; 53(2):177-81. PubMed ID: 10931098
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the timing to reduce the initial dose of antithyroid drugs in patients with Graves' disease.
Nagayama Y; Eishima K; Hirayu H; Yamashita S; Ashizawa K; Matsuo K; Inoue S; Harakawa S; Morita S; Izumi M
Endocrinol Jpn; 1990 Dec; 37(6):769-75. PubMed ID: 1714371
[TBL] [Abstract][Full Text] [Related]
9. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
Kubota S
Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
[TBL] [Abstract][Full Text] [Related]
10. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
[TBL] [Abstract][Full Text] [Related]
11. Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves' disease influencing the therapeutic efficacy.
Molnár I; Szentmiklósi JA; Gesztelyi R; Somogyiné-Vári É
Clin Exp Med; 2019 May; 19(2):245-254. PubMed ID: 30610492
[TBL] [Abstract][Full Text] [Related]
12. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
Abuid J; Larsen PR
J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study.
Mazza E; Carlini M; Flecchia D; Blatto A; Zuccarini O; Gamba S; Beninati S; Messina M
J Endocrinol Invest; 2008 Oct; 31(10):866-72. PubMed ID: 19092290
[TBL] [Abstract][Full Text] [Related]
14. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
Momotani N; Noh JY; Ishikawa N; Ito K
J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
16. Studies on the T3 suppression test by the 24-hour thyroidal 131I uptake in patients with Graves' disease: comparison of the effects of propylthiouracil and methylmercaptoimidazole.
Kobayashi I; Maruta S; Mori M; Ishii H; Ishihara H; Iriuchijima T; Takahashi M; Shimomura Y; Fukuda H
Endocrinol Jpn; 1983 Aug; 30(4):491-7. PubMed ID: 6200318
[TBL] [Abstract][Full Text] [Related]
17. Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease.
Santos RB; Romaldini JH; Ward LS
Thyroid; 2004 Jul; 14(7):525-30. PubMed ID: 15307942
[TBL] [Abstract][Full Text] [Related]
18. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
19. Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man.
Saberi M; Sterling FH; Utiger RD
J Clin Invest; 1975 Feb; 55(2):218-23. PubMed ID: 1173242
[TBL] [Abstract][Full Text] [Related]
20. Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.
Romaldini JH; Werner MC; Rodrigues HF; Teixeira VL; Werner RS; Farah CS; Bromberg N
J Endocrinol Invest; 1986 Jun; 9(3):233-8. PubMed ID: 2428860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
